Center-Authored Papers

Filters: Author is Thomas Budd, G  [Clear All Filters]
2004
Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S.  2004.  A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.. Breast cancer research and treatment. 85(2):143-50. Abstract
2013
Zirpoli GR, Brennan PM, Hong C-C, McCann SE, Ciupak G, Davis W, Unger JM, Thomas Budd G, Hershman DL, Moore HCF et al..  2013.  Supplement use during an intergroup clinical trial for breast cancer (S0221).. Breast cancer research and treatment. 137(3):903-13. Abstract
Yao S, Sucheston LE, Zhao H, Barlow WE, Zirpoli G, Liu S, Moore HCF, Thomas Budd G, Hershman DL, Davis W et al..  2013.  Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.. The pharmacogenomics journal. Abstract